Evaluation efficacy of Azithromycin in prophylaxis of bone marrow transplant complicatio

Phase 2

• Conditions: Condition 1: Acute myeloblastic leukaemia. Condition 2: Acute lymphoblastic leukaemia. Condition 3: Chronic myeloid leukaemia. Condition 4: Multiple myeloma.; Acute myeloblastic leukaemia; Acute lymphoblastic leukaemia; Chronic myeloid leukaemia; Multiple myeloma

• Registration Number: IRCT201403281030N16
• Lead Sponsor: Hematology, Oncology and SCT Research Center

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

age between 16-60 years old; malignant hematologic disease; allogeneic stem cell transplantation and first stem cell transplantation.
Exclusion criteria: age below 16 years old; non malignant disease; second stem cell transplantation.

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Acute GVHD. Timepoint: Every week till 100 day after transplantation. Method of measurement: Clinical assessment.

Secondary Outcome Measures

Name	Time	Method
Oral mucositis. Timepoint: Every week till 100 day after transplantation. Method of measurement: Clinical assessment.